Quick Answer
FENNEC PHARMACEUTICALS INC. reported Operating Income of -$6.28 million for fiscal year 2025.
FENNEC PHARMACEUTICALS INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$6.28M | -344.6% |
| 2024 | $2.57M | +120.1% |
| 2023 | -$12.77M | +43.5% |
| 2022 | -$22.59M | -31.2% |
| 2021 | -$17.22M | +3.7% |
| 2020 | -$17.89M | -37.5% |
| 2019 | -$13.01M | -25.0% |
| 2018 | -$10.41M | -49.7% |
| 2017 | -$6.95M | -142.1% |
| 2016 | -$2.87M | -51.9% |
| 2015 | -$1.89M | +34.3% |
| 2014 | -$2.88M | -49.0% |
| 2013 | -$1.93M | +46.7% |
| 2012 | -$3.62M | -5.3% |
| 2011 | -$3.44M | +25.3% |
| 2010 | -$4.60M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$189.0K | +96.4% | +93.1% |
| June 30, 2025 | -$2.73M | +45.8% | -238.1% |
| March 31, 2025 | -$808.0K | -105.9% | +84.5% |
| September 30, 2024 | -$5.20M | -411.5% | -3.2% |
| June 30, 2024 | -$5.04M | -8.0% | -136.7% |
| March 31, 2024 | $13.74M | +360.8% | +1451.3% |
| September 30, 2023 | -$1.02M | +87.1% | +78.2% |
| June 30, 2023 | -$4.67M | +6.8% | +11.5% |
- FENNEC PHARMACEUTICALS INC. showed a decrease of -344.6% in Operating Income compared to the prior fiscal year.
- Over the 2010–2025 period, FENNEC PHARMACEUTICALS INC.’s operating income has declined by 36.4% (from -$4.60 million to -$6.28 million).
- The most recent figure is from FENNEC PHARMACEUTICALS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: